Clinical trial
CD19/CD20 Dual-CAR-T for Patients With B-cell Lymphoma
NCT04260932 is registered in ClinicalTrials.gov with Hebei Yanda Ludaopei Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- CD19/CD20 Dual-CAR-T for Patients With B-cell Lymphoma
- Lead sponsor
- Hebei Yanda Ludaopei Hospital
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- March 1, 2020
- Completion date
- September 10, 2021
- Enrollment
- 12 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
b-cell lymphoma